Intravascular lithotripsy versus rotational atherectomy for coronary atherosclerosis calcification: a systematic

Pirel Aulia Baravia1, Faqrizal Ria Qhabibi2, Isman Firdaus3

  • 1University of Brawijaya, Malang, Indonesia. pirelaulia@gmail.com.

Insights

Intravascular lithotripsy (IVL) shows similar procedural outcomes to rotational atherectomy (RA) but offers lower short-term mortality and major adverse cardiac events. Long-term data suggests comparable MACE rates between IVL and RA.

Area of Science:

  • Cardiovascular Interventions
  • Medical Device Technology
  • Interventional Cardiology

Background:

  • Intravascular lithotripsy (IVL) is an emerging strategy for modifying coronary artery calcification (CAC).
  • Limited comparative evidence exists for IVL efficacy versus rotational atherectomy (RA).

Purpose of the Study:

  • To compare the efficacy and safety of IVL versus RA in patients with moderate-to-severe CAC.
  • Evaluate outcomes including major adverse cardiac events (MACE), mortality, and procedural success.

Main Methods:

  • Systematic search of observational studies and randomized controlled trials (RCTs) up to March 2025.
  • Meta-analysis of 968 patients (418 IVL, 550 RA) using Mantel-Haenszel risk ratios and inverse variance mean differences.
  • Primary endpoint: MACE; Secondary endpoints: mortality, complications, procedural outcomes.

Main Results:

  • IVL demonstrated lower in-hospital MACE (1.5% vs. 5.3%) and all-cause mortality (1.6% vs. 5.4%) compared to RA.
  • Longer-term follow-up showed comparable MACE rates (4.3% vs. 7.7%) but continued lower all-cause mortality with IVL (2.5% vs. 7.0%).
  • No significant differences in myocardial infarction, dissection, perforation, or slow/no-reflow; procedural success and efficiency were similar.

Conclusions:

  • IVL and RA exhibit comparable procedural outcomes and periprocedural complication rates.
  • IVL is associated with reduced short-term all-cause mortality and MACE.
  • While long-term MACE rates appear similar, IVL maintains an advantage in reducing all-cause mortality.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...